Ahmad Khattab, DO
Pain Medicine · Tulsa, OKNPI 1437569639
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,771 of the $6,751 with a category attached, or 70.7%. 22 manufacturers reported payments, led by Spinal Simplicity, LLC at 26.5% of the total. Reporting peaked in 2021 at $2,272 and has fallen 54.8% since, to $1,027 in 2025.
Across 162 payments — averaging $41.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spinal Simplicity, LLC$2K
- Abbott$2K
- Boston Scientific$468
- Nevro Corp.$450
- Collegium Pharmaceutical, Inc.$403
- Globus Medical$375
- plus $2K from 16 others
What the payments were for
- Travel & lodging$5458%
- Food & beverage$4,77171%
- Education$1,43521%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spinal Simplicity, LLC | 2 | $1,787 |
| Abbott | 45 | $1,648 |
| Boston Scientific | 12 | $468 |
| Nevro Corp. | 12 | $450 |
| Collegium Pharmaceutical, Inc. | 30 | $403 |
| Globus Medical | 6 | $375 |
| SPR Therapeutics, Inc | 6 | $257 |
| Stryker | 5 | $239 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $220 |
| Medtronic | 4 | $180 |
| Saluda Medical Americas, Inc. | 8 | $162 |
| Si-bone, Inc. | 1 | $136 |
| Novartis | 1 | $114 |
| Scilex Pharmaceuticals Inc. | 5 | $87 |
| Tonix Medicines, Inc. | 3 | $68 |
| Vertex | 2 | $42 |
| Valinor Pharma, LLC | 2 | $31 |
| Lilly USA, LLC | 2 | $25 |
| AbbVie | 1 | $15 |
| GRT US Holding, Inc. | 1 | $15 |
| Zimmer Biomet | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HA MINUTEMAN G3-R$1,787
- Proclaim Family of SCS IPGs$693
- Senza$250
- SPECTRA WAVEWRITER$224
- CORRIDOR$176
- SPINEJACK$157
- PROCLAIM$139
- INTELLIS ADAPTIVESTIM$117
- ENTRESTO$114
- SPRINT PNS System$109
How this compares
$6,751 in reported general payments places this provider in the 70th percentile of 68 pain medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,150 | $40,486 |
| BelbucaBuprenorphine Hcl | 45 | $28,581 |
| RelistorMethylnaltrexone Bromide | 12 | $24,555 |
| Xtampza ErOxycodone Myristate | 30 | $23,950 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 562 | $20,400 |
| MovantikNaloxegol Oxalate | 30 | $14,540 |
| Buprenorphine | 86 | $12,895 |
| Gabapentin | 508 | $6,434 |
| Tizanidine Hcl | 387 | $6,051 |
| Pregabalin | 294 | $5,863 |
| Tramadol Hcl | 319 | $3,161 |
| Oxycodone Hcl | 154 | $2,604 |
| Morphine Sulfate ErMorphine Sulfate | 79 | $2,023 |
| Baclofen | 85 | $1,775 |
| Lidocaine | 25 | $1,599 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $403 | $52,53275 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $220 | $24,55512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 68 pain medicine providers in Oklahoma.
Other pain medicine in Tulsa
- Brian TorgersonTulsa$13K
- Lam NguyenTulsa$11K
- Jayen PatelTulsa$10K
- Hugo SalgueroTulsa$10K
- Adam WallaceTulsa$8K
- Kenneth ReedTulsa$7K
- David DoTulsa$6K
- Emad Attallah-WasifTulsa$4K
- Leslie ChanTulsa$4K
- Chancen HallTulsa$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.